Genome Medical is making genetic care accessible and accessible to patients through access to genetic services seven days a week. By collaborating with health systems, molecular testing laboratories and life sciences organizations, Genome Medical is expanding the practice and impact of genomic medicine to improve patient care.
A great example of how to do this is supporting biopharmaceutical organizations in accelerating the design, development and time to launch of life-enhancing therapeutics.
Although they had worked with biopharmaceutical companies in a variety of ways, they knew there was an opportunity to expand their reach and impact.
Data are formatted at the clinical level
To help address this opportunity, Genome Medical has begun working with a vendor called xCures, which takes medical data in a variety of formats and converts it into a clinical-grade format. , reasonable for patients as well as doctors to use.
“Partnering with xCures gives us the opportunity to help our partners further accelerate clinical trials by identifying trial participants,” said Jill Davies, CEO of Genome Medical. Test meets clinical standards. “With xCures, we can augment the patient data we already have – adding additional patient clinical history from the EHR, such as diagnoses, medications, previous treatments, etc.”
Genome Medical provides genetic counseling services to more than 6,000 patients each month. Through a partnership with xCures and with patient consent, medical records are accessed within minutes through a secure health information exchange and search platform.
“After taking in an additional view of the patient’s clinical history, we apply an AI algorithm that provides inclusion/exclusion (I/E) criteria to detect conditions that are eligible individuals for specific clinical trials”. “By adding additional clinical data to each record through xCures, we have a strong and continuous patient growth base to identify and enable clinical trials.
“And with our deep clinical and genetic expertise and strong patient-provider relationships, we are changing the slow, cumbersome trial enrollment process,” she added. according to tradition”.
Huge network of experts
Genome Medical claims to have the nation’s largest network of telemedicine genetics specialists with an average of 10 years of clinical experience and coverage of many clinical specialties including oncology, reproductive health, cardiovascular, pediatrics, rare diseases and proactive health.
“This helps us help our partners and their patients navigate the often scary and confusing diagnostic journey to finding a clinical trial or genetic therapy that helps them manage their condition,” said Davies. My health is better.”
The organization’s use cases and outcomes range from high-incidence chronic diseases to low-incidence rare diseases. For example, Davies reported:
- A clinical trial needs participants for an extremely rare disease that affects 1 in 70,000-100,000 people. Genome Medical has identified seven eligible patients.
- A clinical trial for a common chronic disease requires complex criteria to match a patient, including a coded diagnosis, a specific prescription within the past 12 months, and no concomitant use. other excluded drugs and treatments, ruled out certain other conditions, etc. The organization identified 161 patients.
- And a cancer clinical trial needs patients with specific genetic markers plus exclusion of previous treatments. The organization has identified 33 patients.
“During the patient intake process to provide genetic counseling services, we may offer patients the option to be contacted again by Genome Medical if we become aware of a potential clinical trial,” Davies noted. related to their clinical condition”.
Review complete clinical records
“So, after meeting the I/E criteria I mentioned, our team of genetic experts conducts a full clinical profile review for all eligible patients,” she continued. conditions that meet the criteria”. “For those who do, we can contact them directly and if interested, provide them with clinical trial enrollment information.”
The process of identifying, reviewing, contacting back, and connecting each of these groups was completed in less than two weeks.
Davies advises his colleagues: “Leveraging available clinical data and technology is critical to driving successful clinical trials, but even with AI, a combination of elements is needed. human factors – to ensure quality care and patient engagement”. “At Genome Medical, that human element is our clinical expertise and trusted patient/provider relationships.”
Follow Bill’s HIT news on LinkedIn: Bill Siwicki
Email him: [email protected]
Healthcare IT News is a publication of HIMSS Media.
